[O1–14–03]: THE ROLE OF COMPLEMENT C3 AND C3AR RECEPTOR IN TAU PATHOLOGY IN ALZHEIMER's DISEASE
Alexandra Litvinchuk(Hope Center for Neurological Disorders), Hui Zheng(Baylor College of Medicine), Fading Chen(Baylor College of Medicine), Ying‐Wooi Wan(Baylor College of Medicine), Allysa Cole(Baylor College of Medicine), Zhangdong Liu(Baylor College of Medicine)
Cited by 2
Related Papers
Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease
|Journal of Neuroscience|2016|600
Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease
|Neuron|2018|525
Practical considerations for choosing a mouse model of Alzheimer’s disease
|Molecular Neurodegeneration|2017|455
Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging
|Journal of Clinical Investigation|2020|246